Vascular Solutions Inc. (NASDAQ:VASC) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $49.77 and last traded at $48.61, with a volume of 24,374 shares traded. The stock had previously closed at $48.46.

Several brokerages recently issued reports on VASC. Canaccord Genuity reiterated a “buy” rating on shares of Vascular Solutions in a research note on Wednesday, August 10th. Zacks Investment Research upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating and set a $52.00 price target for the company in a research note on Thursday, July 28th. TheStreet upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research note on Monday, July 25th. Sidoti lowered shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price target for the company. in a research note on Tuesday, July 12th. Finally, Piper Jaffray Cos. increased their price target on shares of Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 26th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Vascular Solutions has a consensus rating of “Buy” and an average price target of $47.38.

The stock has a market capitalization of $856.88 million and a price-to-earnings ratio of 90.72. The firm’s 50 day moving average price is $46.05 and its 200-day moving average price is $38.07.

Vascular Solutions (NASDAQ:VASC) last posted its quarterly earnings data on Monday, July 25th. The medical device company reported $0.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.03. The firm had revenue of $41.20 million for the quarter, compared to the consensus estimate of $41.40 million. The company’s revenue was up 9.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.29 EPS. Equities research analysts predict that Vascular Solutions Inc. will post $1.24 earnings per share for the current year.

In other news, CEO Howard Root sold 40,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $45.11, for a total transaction of $1,804,400.00. Following the completion of the sale, the chief executive officer now directly owns 347,840 shares of the company’s stock, valued at $15,691,062.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP William Rutstein sold 10,011 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $46.26, for a total transaction of $463,108.86. The disclosure for this sale can be found here.

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.